Unique ID issued by UMIN | UMIN000036277 |
---|---|
Receipt number | R000041318 |
Scientific Title | Self-compassion and Mindfulness integrated online program for Living with Eczema - A randomize controlled trial (SMiLE Study) |
Date of disclosure of the study information | 2019/03/22 |
Last modified on | 2022/10/09 13:05:37 |
Self-compassion and Mindfulness integrated online program for Living with Eczema - A randomize controlled trial (SMiLE Study)
SMiLE Study
Self-compassion and Mindfulness integrated online program for Living with Eczema - A randomize controlled trial (SMiLE Study)
SMiLE Study
Japan |
atopic dermatitis
Dermatology |
Others
NO
This study will be conducted to evaluate the effectiveness of the mindfulness and self-compassion integrated online psychoeducation program for people with atopic dermatitis using RCT design.
Safety,Efficacy
Disease specific quality of life, DLQI-J.
Outcomes will be measured at baseline, mid-term, post-intervention, 4-week follow-up, and 26-week follow-up (26-week is only for intervention group).
Patient Oriented Eczema Measure (POEM), Itch related scales, Self-Compassion Scale (SCS-J), Freiburg Mindfulness Inventory, Hospital anxiety and depression scale(HADS) , Internalized Shame Scale, treatment adherence, home practice, and program feedback
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
2
Educational,Counseling,Training
Behavior,custom |
8-week mindfulness and self-compassion online group sessions once weekly, 90 min per session
Waitlist
18 | years-old | <= |
65 | years-old | > |
Male and Female
Fulfilling all of the following inclusion criteria:
1) >=18 yo <65 yo
2) Have been diagnosed with atopic dermatitis
3) Under treatment/observation and feeling itchy skin
4) >=6 score of Dermatology Life Quality Index at baseline
5) Have internet access to participate in online format program
6) Attend all the sessions and home practice
7) Voluntary participation and comprehension of the purpose or risks of this study
Either:
1) Under Dupixent treatment at enrollment or prior to 4-week follow-up assessment
2) Psychosis, personality disorder, PTSD, acute stress disorder or Developmental disability
3) Under mental health treatment for other diagnosis, and the therapist considers participation would be inappropriate
4) Under psychotherapy treatment at enrollment or prior to 4-week follow-up assessment
5) Have attended mindfulness or compassion programs, or will attend prior to 4-week follow-up assessment
6) Inability to understand Japanese
7) This study's researchers or their family members
8) Individuals whom researchers judge to inappropriate to participate in this study
116
1st name | Sanae |
Middle name | |
Last name | Kishimoto |
Kyoto University
Graduate School of Public Health
606-8501
Yoshida Konoe-cho, Sakyo-ku, Kyoto
075-753-9491
info@smilestudy.jp
1st name | Sanae |
Middle name | |
Last name | Kishimoto |
Kyoto University
Graduate School of Public Health
606-8501
Yoshida Konoe-cho, Sakyo-ku, Kyoto
075-753-9491
https://smilestudy.jp
info@smilestudy.jp
Kyoto University
Mental Health Okamoto Memorial Foundation
Pfizer Health Research Foundation
KDDI Foundation
Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science
Non profit foundation
Kyoto University
Yoshida Konoe-cho, Sakyo-ku, Kyoto
075-753-4680
ethcom@kuhp.kyoto-u.ac.jp
NO
2019 | Year | 03 | Month | 22 | Day |
Unpublished
No longer recruiting
2019 | Year | 01 | Month | 18 | Day |
2019 | Year | 03 | Month | 08 | Day |
2019 | Year | 03 | Month | 22 | Day |
2023 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 22 | Day |
2022 | Year | 10 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041318